Late-breaking trial results for obefazimod show significant efficacy, positioning the first-in-class oral therapy in a competitive market.
The ongoing US government shutdown is delaying critical jobs and inflation reports, creating an information vacuum for investors and the Federal Reserve.
Proposed 'OBBBA' legislation would hike tax credits for new domestic chip plants to 35%, aiming to accelerate 'Made in America' initiatives.
Combination therapy approval for small cell lung cancer offers a new standard of care and a bullish signal for the pharmaceutical sector.
Landmark bill grants Uber and Lyft drivers collective bargaining rights, signaling a potential shift in the gig work model.
First-of-its-kind maintenance therapy approved for extensive-stage small cell lung cancer, a historically difficult-to-treat malignancy.
The designation for ALTO-101 targets cognitive impairment, a debilitating aspect of schizophrenia with no currently approved treatments.
Investor demand drives prices to new all-time highs as Bitcoin balances on exchanges plummet to a six-year low.